• Novyra Pharmachem's board will meet on May 16, 2026 to consider a capital reduction proposal under Companies Act 2013.
• The board will also approve AGM notice, fix book closure dates, and review FY26 director's and secretarial audit reports.
• The meeting is intimated under SEBI LODR Regulation 29 for corporate governance and shareholder communication purposes.